Kedudukan dalam Saham
#21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Harga Saham
$3.58
Disegerakkan terakhir: 2023-12-15
Perubahan (1 tahun)
0.00%
Perdagangan MDxHealth S.A. (MDXH)
Harga MDXH dengan permodalan pasaran b
Modal pasaran bagi MDxHealth S.A.(MDXH)
Modal Pasaran: $101.57M
Sehingga August 2026, MDxHealth S.A. mempunyai modal pasaran sebanyak $101.57M. Ini menjadikan MDxHealth S.A. syarikat ke-21732nd paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran MDxHealth S.A. dari 2006 hingga 2026
MDXH berbanding dengan 5 teratas yang paling popular stocks
| Harga MDXH |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.211T
|
+5,130,713.72%
|
|
|
|
|
$4.547T
|
+4,476,364.28%
|
|
|
|
|
$4.162T
|
+4,098,034.15%
|
|
|
|
|
$3.593T
|
+3,537,154.86%
|
|
|
|
|
$2.793T
|
+2,749,583.54%
|
